Angcot, Carmen T.

HRN: 22-96-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2023
CO-AMOXICLAV 625MG (TAB)
05/01/2023
05/08/2023
PO
625mg
BID
Infected Wound
Waiting Final Action 
05/02/2023
CEFAZOLIN 1GM (VIAL)
05/02/2023
05/09/2023
IV
1g
7 Days
Open Fracture
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: